RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 301–400 of 1,009
PKA-mediated phosphorylation of the β1-adrenergic receptor promotes Gs/Gi switching
Martin, N. P., Whalen, E. J., Zamah, A. M., Pierce, K. L., & Lefkowitz, R. J. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.002 · Cited by 109
Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues
Hagner, S., Stahl, U., Knoblauch, B., McGregor, G. P., & Lang, R. E. (2002) · Cell and Tissue Research · doi:10.1007/s00441-002-0616-x · Cited by 118
“The function and ligand specificity of CRLR was found to depend on the coexpression of either of the so-called receptor-activity-modifying proteins (RAMPs) ( McLatchie et al. 1998 ).”
BackgroundResultMeningeal lymphatic drainage: novel insights into central nervous system disease
Zhang, Q., Niu, Y., Li, Y., Xia, C., Chen, Z., Chen, Y., & Feng, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02177-z · Cited by 112
Padilla, B. E., Cottrell, G. S., Roosterman, D., Pikios, S., Muller, L., Steinhoff, M., & Bunnett, N. W. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704053 · Cited by 102
Shichiri, M. (1999) · Molecular Endocrinology · doi:10.1210/me.13.8.1353 · Cited by 105
“Notably, it has recently been shown that calcitonin-receptor-like receptor functions as either CGRP receptor or adrenomedullin receptor depending upon whether receptor activity-modifying protein (RAMP) 1 or RAMP2 is simultaneously expressed, respectively (35).”
BackgroundPredicting therapeutic value in the lead optimization phase of drug discovery
Kenakin, T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1110 · Cited by 114
Specialized membrane-localized chaperones prevent aggregation of polytopic proteins in the ER
Kota, J., & Ljungdahl, P. O. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408106 · Cited by 124
“For example, in mammalian cells, receptorassociated membrane proteins determine the intracellular transport and ligand specificity of G protein–coupled receptors (McLatchie et al., 1998; Bermak et al., 2001), and in Caenorhabditis elegans, a select subset of odorant receptors require the action of ODR-4 to be correctl…”
BackgroundCalcitonin Gene-Related Peptide Induces IL-8 Synthesis in Human Corneal Epithelial Cells
Tran, M. T., Ritchie, M. H., Lausch, R. N., & Oakes, J. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4307 · Cited by 108
“The CRLR gene product has been identified as the CGRP-binding component of the CGRP receptor (26).”
BackgroundInfluentialBower, R. L., & Hay, D. L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13496 · Cited by 104
“Three RAMP genes are expressed in humans, encoding RAMP1, RAMP2 and RAMP3, with 31% sequence identity between them (McLatchie et al., 1998).”
BackgroundZhang, J. V., Jahr, H., Luo, C.-W., Klein, C., Kolen, K. V., Donck, L. V., De, A., Baart, E. B., Li, J., Moechars, D., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0569 · Cited by 109
Modulation of immune responses by the neuropeptide CGRP
Holzmann, B. (2011) · Amino Acids · doi:10.1007/s00726-011-1161-2 · Cited by 108
“Translocation to the cell membrane and ligand binding of the CGRP receptor are dependent on the formation of heterodimers between CLR and RAMP1 (McLatchie et al. 1998; Hilairet et al. 2001).”
BackgroundCGRP Receptor Antagonism and Migraine
Edvinsson, L. I., & Ho, T. W. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.02.004 · Cited by 104
Pharmacology of the human CGRP1 receptor in Cos 7 cells
Bailey, R. J., & Hay, D. L. (2005) · Peptides · doi:10.1016/j.peptides.2005.11.014 · Cited by 102
CGRP and migraine: Could PACAP play a role too?
Kaiser, E. A., & Russo, A. F. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.010 · Cited by 109
“G protein-coupled receptor, and RAMP1 are required for trafficking to the cell surface and for CGRP binding (McLatchie et al., 1998).”
BackgroundMode and site of action of therapies targeting CGRP signaling
Labastida‐Ramírez, A., Caronna, E., Gollion, C., Stanyer, E. C., Dapkutė, A., Braniste, D., Naghshineh, H., Mekša, L., Chkhitunidze, N., Gudadze, T., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01644-8 · Cited by 104
“Moreover, the CLR:RAMP1 complex allows reaching the plasma membrane and binding CGRP with high affinity [34].”
BackgroundThe heart as an endocrine organ
Ogawa, T., & de Bold, A. J. (2014) · Endocrine Connections · doi:10.1530/ec-14-0012 · Cited by 107
Wang, L., Martin, B., Brenneman, R., Luttrell, L. M., & Maudsley, S. R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156380 · Cited by 109
“, 2006), receptor activity-modifying proteins/calcitonin gene-related peptide-receptor component protein (McLatchie et al., 1998; Evans et al., 2000), and PDZ-domain containing proteins (Hall et al.”
Migraine therapeutics differentially modulate the CGRP pathway
Bhakta, M., Vuong, T., Taura, T., Wilson, D. S., Stratton, J., & Mackenzie, K. D. (2021) · Cephalalgia · doi:10.1177/0333102420983282 · Cited by 106
“While CLR alone does not appear to operate as a functional receptor, CTR alone is a receptor for calcitonin (1,10).”
BackgroundMethodRoy, S., Rached, M., & Gallo-Payet, N. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0041 · Cited by 100
Regulation of G Protein-Coupled Receptor Function by Na+/H+ Exchange Regulatory Factors
Ardura, J. A., & Friedman, P. A. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004176 · Cited by 108
“Coexpression of RAMP1 with CRLR yields a functional calcitonin gene-related peptide receptor, whereas coexpression of RAMP2 or RAMP3 with CRLR produces a receptor responsive to adrenomedullin (McLatchie et al., 1998; Bühlmann et al., 1999).”
BackgroundTargeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
Moore, E. L., & Salvatore, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01633.x · Cited by 105
“The CGRP receptor is a multimeric complex consisting of the seven-transmembrane GPCR-designated CT receptor-like receptor (CLR) as well as a single transmembrane proteindesignated receptor activity-modifying protein (RAMP) 1 (McLatchie et al., 1998).”
BackgroundInfluentialAdrenomedullin regulates blood–brain barrier functions in vitro
Kis, B., Deli, M. A., Kobayashi, H., Ábrahám, C. S., Yanagita, T., Kaiya, H., Isse, T., Nishi, R., Gotoh, S., Kangawa, K., et al. (2001) · Neuroreport · doi:10.1097/00001756-200112210-00055 · Cited by 95
Adrenomedullin: angiogenesis and gene therapy
Nagaya, N., Mori, H., Murakami, S., Kangawa, K., & Kitamura, S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00662.2004 · Cited by 103
“Recently, a seven-transmembrane G-protein-coupled receptor, calcitonin receptor-like receptor (CRLR), and receptor activity modifying proteins (RAMPs) have been recognized as integral components of the AM signaling system (38, 43).”
BackgroundAdvances in the molecular understanding of GABAB receptors
Billinton, A., Ige, A. O., Bolam, J. P., White, J. H. M., Marshall, F. H., & Emson, P. C. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01815-4 · Cited by 99
Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion
Edvinsson, L. I., Grell, A.-S., & Warfvinge, K. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01493-z · Cited by 103
A tumor microenvironment-based prognostic index for osteosarcoma
Wu, C., Gong, S., Duan, Y., Deng, C., Kallendrusch, S., Berninghausen, L. K., Osterhoff, G., & Schopow, N. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00917-3 · Cited by 107
“As for RAMP1, this gene is a member of the receptor activity modifying proteins (RAMP) family, is involved in the terminal glycosylation, maturation and presentation of calcitonin gene-related peptide (CGRP) receptors to the cell surface [53].”
BackgroundBarth, S., Riediger, T., Lutz, T. A., & Rechkemmer, G. (2003) · Brain Research · doi:10.1016/j.brainres.2003.10.040 · Cited by 98
Gacche, R. N., & Meshram, R. J. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.10.001 · Cited by 106
“When RAMP1 is coexpressed with CLR, such a complex plays signal transduction related to CGRP while CLR is also known to co-expressed together with either of RAMP2 or RAMP3 to generate receptor that plays some another role (McLatchie et al., 1998).”
BackgroundGazzieri, D., Trevisani, M., Springer, J., Harrison, S., Cottrell, G. S., Andrè, E., Nicoletti, P., Massi, D., Zecchi, S., Nosi, D., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.018 · Cited by 98
CGRP and migraine: neurogenic inflammation revisited
Geppetti, P., Capone, J. G., Trevisani, M., Nicoletti, P., Zagli, G., & Tola, M. R. (2005) · The Journal of Headache and Pain · doi:10.1007/s10194-005-0153-6 · Cited by 109
“The puzzle was solved after the discovery of the receptor activity-modifying protein (RAMP), a single transmembrane domain protein with 148 amino acids necessarily required to associate with CL to confer receptor activity [33].”
BackgroundAdrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion
Keleg, S., Kayed, H., Jiang, X., Penzel, R., Giese, T., Büchler, M. W., Frieß, H., & Kleeff, J. H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22596 · Cited by 106
Shen, W.-C., Davidson, R. C., Cox, G. M., & Heitman, J. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.3.366-377.2002 · Cited by 97
“neoformans expresses homologs of the mammalian RAMP proteins, which bind to and alter the ligand specificity of G-protein-coupled receptors (43).”
BackgroundCGRP in the trigeminovascular system: a role for CGRP , adrenomedullin and amylin receptors?
Walker, C. S., & Hay, D. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12129 · Cited by 109
“In individual tissues, the pharmacological phenotype is complicated by likely co-expression of multiple receptor components which can give rise to several different receptor subtypes (McLatchie et al., 1998).”
BackgroundMethodInfluentialInteraction with Protocadherin-γ Regulates the Cell Surface Expression of Protocadherin-α
Murata, Y., Hamada, S., Morishita, H., Mutoh, T., & Yagi, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408771200 · Cited by 97
A Specific Heat Shock Protein Enhances the Expression of Mammalian Olfactory Receptor Proteins
Neuhaus, E. M., Mashukova, A., Zhang, W., Barbour, J., & Hatt, H. (2006) · Chemical Senses · doi:10.1093/chemse/bjj049 · Cited by 112
“Most GPCRs can be functionally expressed in heterologous cells, although there are exceptions as, for example, the calcitonin receptor–like receptor, which is only trafficking to the plasma membrane if a member of the receptor activity modifying protein family of proteins is present (McLatchie et al., 1998).”
BackgroundAmici, M. D., Dallanoce, C., Holzgrabe, U., Tränkle, C., & Mohr, K. (2009) · Medicinal Research Reviews · doi:10.1002/med.20166 · Cited by 106
“Functional CGRP receptors have been characterized as heterodimers of the CT receptorlike GPCR (CLR) and a single transmembrane domain protein called receptor activity modifying protein type 1 (RAMP1).(251,257,258) On the other hand, AM receptors are heterodimers formed by CLR and RAMP type 2 or RAMP type 3.”
BackgroundPossible sites of action of the new calcitonin gene-related peptide receptor antagonists
Eftekhari, S., & Edvinsson, L. I. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610388343 · Cited by 97
“…a complex of a seven transmembrane spanning protein, calcitonin receptor-like receptor (CLR), a single transmembrane-spanning protein designated receptor activity modifying protein (RAMP)1 [Mclatchie et al. 1998], and an intracellular protein, receptor component protein (RCP) [Evans et al. 2000].”
BackgroundArmour, S. L., Foord, S., Kenakin, T., & Chen, W.-J. (1999) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00074-5 · Cited by 96
Self-citationRAMPs: the past, present and future
Parameswaran, N., & Spielman, W. S. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.09.006 · Cited by 108
Brainstem mechanisms of amylin-induced anorexia
Potes, C. S., & Lutz, T. A. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.001 · Cited by 100
“The RAMPs are believed to regulate the transport of the core receptors to the cell surface and their glycosylation state, which determines ligand specificity [38,39].”
BackgroundBIOLOGICAL AND CLINICAL ROLES OF ADRENOMEDULLIN IN CIRCULATION CONTROL AND CARDIOVASCULAR DISEASES
Eto, T., Kitamura, K., & Kato, J. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03047.x · Cited by 103
“More recently, McLatchie et al.38 have shown that calcitonin receptor-like receptor (CRLR) functions as a CGRP or AM receptor that is dependent on accessory molecular modification by the action of receptor activity modifying protein (RAMP) 1 or 2.”
BackgroundWeston, C., Winfield, I., Harris, M., Hodgson, R., Shah, A., Dowell, S. J., Mobarec, J. C., Woodlock, D. A., Reynolds, C. A., Poyner, D. R., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751362 · Cited by 95
“The formation of this heterodimer is obligatory for receptor function and efficient translocation of both subunits to the cell surface (13).”
BackgroundCalcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family
Katafuchi, T., Kikumoto, K., Hamano, K., Kangawa, K., Matsuo, H., & Minamino, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207970200 · Cited by 95
CXCR7 Targeting and Its Major Disease Relevance
Wang, C., Chen, W., & Shen, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00641 · Cited by 100
Koyama, T., Ochoa‐Callejero, L., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Iinuma, N., Arai, T., Yoshizawa, T., Iesato, Y., Yang, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000756 · Cited by 104
“AM is a member of the calcitonin superfamily and acts via a G protein–coupled 7-transmembrane domain receptor, calcitonin receptor–like receptor.(23,24) The specificity of calcitonin receptor–like receptor for its ligands is regulated by a group of 3 receptor activity–modifying proteins, RAMP1, -2, and -3.”
BackgroundOlfactory Receptor Trafficking Involves Conserved Regulatory Steps
Gimelbrant, A. A., Haley, S., & McClintock, T. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005433200 · Cited by 95
On the analysis of ligand-directed signaling at G protein-coupled receptors
Ehlert, F. J. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0260-4 · Cited by 94
The Pharmacology of Adrenomedullin Receptors and Their Relationship to CGRP Receptors
Hay, D. L., Conner, A. C., Howitt, S. G., Smith, D. M., & Poyner, D. R. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:1-2:105 · Cited by 94
“However, in humans, there are many tissues where RAMP3 is the most abundant mRNA species (McLatchie et al., 1998).”
BackgroundInfluentialCalcitonin gene‐related peptide ( CGRP ): A novel target for Alzheimer's disease
Singh, Y. P., Gupta, G., Shrivastava, B., Dahiya, R., Tiwari, J., Ashwathanarayana, M., Sharma, R. K., Agrawal, M., Mishra, A., & Dua, K. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12696 · Cited by 93
Neuroimmune Pathophysiology in Asthma
Pavón-Romero, G. F., Serrano-Pérez, N. H., García-Sánchez, L., Jiménez, F. R., & Teran, L. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.663535 · Cited by 102
A Female-Specific Role for Calcitonin Gene-Related Peptide (CGRP) in Rodent Pain Models
Paige, C., Plasencia-Fernández, I., Kume, M., Papalampropoulou-Tsiridou, M., Lorenzo, L.-É., David, E. T., He, L., Mejia, G. L., Driskill, C. M., Ferrini, F., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1137-21.2022 · Cited by 93
G protein‐coupled receptors: a count of 1001 conformations
Vauquelin, G., & Liefde, I. V. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00319.x · Cited by 110
Chemosensory signaling in C. elegans
Troemel, E. R. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199912)22:1<1011::aid-bies5>3.0.co;2-v · Cited by 107
Structure and dynamics of the CGRP receptor in apo and peptide-bound forms
Josephs, T. M., Belousoff, M. J., Liang, Y.-L., Piper, S. J., Cao, J., Garama, D. J., Leach, K., Gregory, K. J., Christopoulos, A., Hay, D. L., et al. (2021) · Science · doi:10.1126/science.abf7258 · Cited by 88
“The CGRPR is a heterodimer of the class B1 GPCR, calcitonin receptor–like receptor (CLR), and receptor activity–modifying protein 1 (RAMP1)—one of three related proteins (RAMP1, RAMP2, and RAMP3) (13), with heterodimerization of CLR with either RAMP2 or RAMP3 forming distinct adrenomedullin (AM) receptors.”
BackgroundClass II G Protein-Coupled Receptors and Their Ligands in Neuronal Function and Protection
Martin, B., de Maturana, R. L., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. R. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:003 · Cited by 99
Receptor Activity-Modifying Proteins: RAMPing up Adrenomedullin Signaling
Gibbons, C., Dackor, R. T., Dunworth, W. P., Fritz-Six, K. L., & Caron, K. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0156 · Cited by 106
“Although the three mammalian RAMPs vary greatly in sequence homology ( 30%) and tissue distribution (53, 59), they share a similar molecular mass (160 amino acids) and structure, which consists of a long extracellular amino terminus, a single transmembrane domain, and a short cytoplasmic carboxy terminus.”
BackgroundAmylin-Induced Central IL-6 Production Enhances Ventromedial Hypothalamic Leptin Signaling
Le Foll, C., Johnson, M. D., Dunn-Meynell, A. A., Boyle, C. N., Lutz, T. A., & Levin, B. E. (2015) · Diabetes · doi:10.2337/db14-0645 · Cited by 87
“There are two splice variants of CTR, 1a and 1b (4,6), and three known RAMP subtypes (RAMP1, 2, 3), providing six possible combinations for expressing the amylin receptor (7).”
BackgroundInsect G protein‐coupled receptors and signal transduction
Broeck, J. V. (2001) · Archives of Insect Biochemistry and Physiology · doi:10.1002/arch.1054 · Cited by 92
TOTSUNE, K., TAKAHASHI, K., MACKENZIE, H. S., MURAKAMI, O., ARIHARA, Z., SONE, M., MOURI, T., BRENNER, B. M., & ITO, S. (2000) · Clinical Science · doi:10.1042/cs0990541 · Cited by 92
Fonin, A. V., Darling, A. L., Kuznetsova, I. M., Turoverov, K. K., & Uversky, V. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03276-1 · Cited by 91
Salvatore, C., Moore, E. L., Calamari, A., Cook, J. J., Michener, M. S., O'Malley, S. S., Miller, P. J., Sur, C., Williams, D. L., Zeng, Z., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163816 · Cited by 91
“A functional CGRP receptor requires coexpression of CLR and RAMP1, whereas when CLR is coexpressed with RAMP2 or RAMP3, a receptor with high affinity for adrenomedullin (AM) is produced (McLatchie et al., 1998).”
BackgroundAdhesion G protein-coupled receptors: opportunities for drug discovery
Bassilana, F., Nash, M., & Ludwig, M. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0039-y · Cited by 97
Calcitonin gene related peptide mediates cardioprotection by remote preconditioning
Wolfrum, S., Nienstedt, J., Heidbreder, M., Schneider, K., Dominiak, P., & Dendorfer, A. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.12.008 · Cited by 91
GABAB Receptors: From Monogamy to Promiscuity
Calver, A. R., Davies, C. H., & Pangalos, M. N. (2002) · Neurosignals · doi:10.1159/000068257 · Cited by 91
Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium
Nikitenko, L. L., MacKenzie, I. Z., Rees, M. C., & Bicknell, R. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.9.811 · Cited by 95
“RAMP1 presents the receptor at the cell surface as a CGRP receptor; RAMP2- and RAMP3transported receptors are adrenomedullin receptors (McLatchie et al., 1998; Kamitani et al., 1999).”
BackgroundLiang, Y.-L., Belousoff, M. J., Fletcher, M. M., Zhang, X., Khoshouei, M., Deganutti, G., Koole, C., Furness, S. G. B., Miller, L. J., Hay, D. L., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00080 · Cited by 87
Gulamhussein, A. A., Uddin, R., Tighe, B. J., Poyner, D. R., & Rothnie, A. J. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183281 · Cited by 90
Eglen, R. M., Bosse, R., & Reisine, T. (2007) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2007.062 · Cited by 90
“140 Studies by McLatchie et al .”
Kaafarani, I., Fernandez-Sauze, S., Berenguer‐Daizé, C., Chinot, O. L., Delfino, C., Dussert, C., Métellus, P., Boudouresque, F., Mabrouk, K., Grisoli, F., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-127852 · Cited by 93
“RAMP1 presents CLR at the plasma membrane as a calcitonin generelated peptide (CGRP) receptor, whereas RAMP2 and RAMP3 present CLR as an AMR (18).”
BackgroundHay, D. L., Christopoulos, G., Christopoulos, A., & Sexton, P. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027953 · Cited by 96
“These data support the importance of Trp74 in RAMP1 in the interaction of BIBN4096BS with CGRP1 and AMY1(a) receptors and identified Glu74 in RAMP3 as the first amino acid in RAMP important for agonist interactions with calcitonin-family receptors.”
BackgroundMethodInfluentialGABAB receptors make it to the top – as dimers
Möhler, H., & Fritschy, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01323-1 · Cited by 90
Eftekhari, S., Gaspar, R. C., Roberts, R., Chen, T., Zeng, Z., Villarreal, S. A., Edvinsson, L. I., & Salvatore, C. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23828 · Cited by 94
“The interaction of CLR with RAMP2 or RAMP3 forms adrenomedullin receptors (McLatchie et al., 1998; Zhang et al., 2007).”
BackgroundSensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs
Darragh, L. B., Nguyen, A. T., Pham, T., Idlett-Ali, S., Knitz, M. W., Gadwa, J., Bukkapatnam, S., Corbo, S., Olimpo, N. A., Nguyen, D., et al. (2024) · Med · doi:10.1016/j.medj.2024.02.002 · Cited by 89
G protein-coupled receptor dimers: Functional consequences, disease states and drug targets
Dalrymple, M. B., Pfleger, K. D. G., & Eidne, K. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.03.004 · Cited by 100
“The importance of RAMPs in GPCR functionality was first established in a study of the calcitonin-receptor-like receptor (CRLR), which revealed that the pharmacological profile of this receptor was determined by its association with a family of novel proteins termed RAMPs (McLatchie et al., 1998).”
BackgroundNoon, L., Franklin, J., King, P., Goulding, N., Hunyady, L., & Clark, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740017 · Cited by 88
“Subsequently, McLatchie et al. (1998) demonstrated that coexpression of the CRLR with one of three RAMPs conferred function as www.endocrinology.org Journal of Endocrinology (2002) 174, 17–25 Downloaded from Bioscientifica.com at 11/18/2022 03:06:08PM via free access either a CGRP receptor or an…”
BackgroundInfluentialRole and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
Kiriyama, Y., & Nochi, H. (2018) · Cells · doi:10.3390/cells7080095 · Cited by 95
Therapeutic targets in pulmonary arterial hypertension
Rhodes, C. J., Davidson, A., Gibbs, J. S. R., Wharton, J., & Wilkins, M. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.002 · Cited by 90
“activity-modifying proteins-2 and -3 (McLatchie et al., 1998) and through several signalling pathways such as cAMP, NO-cGMP and PI3K/Akt (Kato et al.”
BackgroundFamilial glucocorticoid deficiency: New genes and mechanisms
Meimaridou, E., Hughes, C. R., Kowalczyk, J., Guasti, L., Chapple, J. P., King, P., Chan, L. F., Clark, A., & Metherell, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.12.010 · Cited by 94
A historical perspective on the role of sensory nerves in neurogenic inflammation
Valente, J. D. S., & Brain, S. D. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0673-1 · Cited by 88
Martínez, A., Kapas, S., Miller, M.-J., Ward, Y., & Cuttitta, F. (2000) · Endocrinology · doi:10.1210/endo.141.1.7261 · Cited by 86
Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia
Nikitenko, L. L., Smith, D. M., Bicknell, R., & Rees, M. C. P. (2003) · The FASEB Journal · doi:10.1096/fj.02-0993fje · Cited by 85
Hypoxia-induced adrenomedullin production in the kidney
Nagata, D., Hirata, Y., Suzuki, E., Kakoki, M., Hayakawa, H., Goto, A., Ishimitsu, T., Minamino, N., Ono, Y., Kangawa, K., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00361.x · Cited by 89
The melanocortin receptors and their accessory proteins
Ramachandrappa, S., Gorrigan, R. J., Clark, A. J. L., & Chan, L. F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00009 · Cited by 87
Wootten, D., Lindmark, H., Kadmiel, M., Willcockson, H., Caron, K., Barwell, J., Drmota, T., & Poyner, D. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02202.x · Cited by 83
“With both CLR and the calcium sensing receptor, there is a reciprocal interaction, whereby RAMPs also enhance the cell surface expression of the receptor (McLatchie et al., 1998; Bouschet et al., 2005).”
BackgroundExpression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain
Ueda, T., Ugawa, S., Saishin, Y., & Shimada, S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00179-6 · Cited by 96
Molecular pathways in dystonia
Bragg, D. C., Armata, I. A., Nery, F. C., Breakefield, X. O., & Sharma, N. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.015 · Cited by 91
Adrenomedullin – new perspectives of a potent peptide hormone
Schönauer, R. A.-R., Els‐Heindl, S., & Beck‐Sickinger, A. G. (2017) · Journal of Peptide Science · doi:10.1002/psc.2953 · Cited by 89
Hay, D. L., Poyner, D. R., & Quirion, R. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00372 · Cited by 86
“143 by guest on M ay 10, 2022 D ow nloaded from profile of a CGRP1 receptor (McLatchie et al., 1998).”
BackgroundMolecular studies of CGRP and the CGRP family of peptides in the central nervous system
Hendrikse, E. R., Bower, R. L., Hay, D. L., & Walker, C. S. (2018) · Cephalalgia · doi:10.1177/0333102418765787 · Cited by 90
“CLR alone does not appear to act as a functional receptor, whereas CTR is the receptor for calcitonin (16,17).”
Distribution of the GABAB receptor subunit gb2 in rat CNS
Clark, J. A., Mezey, É., Lam, A. S., & Bonner, T. I. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01958-2 · Cited by 86
Edvinsson, L. I., Eftekhari, S., Salvatore, C., & Warfvinge, K. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.10.005 · Cited by 85
“…receptor RAMP1 Receptor activity-modifying protein 1 RCP Receptor component protein PBS Phosphate buffered-saline BSA Bovine serum albumin PFA Paraformaldehyde PBST Phosphate buffered-saline (PBS) containing 0.25% Triton X-100 PET Positron emission tomography GFAP Glial fibrillary acidic protein 3”
BackgroundMethodInfluentialAmylin receptors mediate the anorectic action of salmon calcitonin (sCT)
Lutz, T. A., Tschudy, S., Rushing, P. A., & Scharrer, E. (2000) · Peptides · doi:10.1016/s0196-9781(99)00208-9 · Cited by 85
Zandawala, M., Moghul, I., Yáñez-Guerra, L. A., Delroisse, J., Abylkassimova, N., Hugall, A. F., O’Hara, T. D., & Elphick, M. R. (2017) · Open Biology · doi:10.1098/rsob.170129 · Cited by 90
Alternative splicing generates a novel isoform of the rat metabotropic GABABR1 receptor
Pfaff, T., Malitschek, B., Kaupmann, K., Prézeau, L., Pin, J., Bettler, B., & Karschin, A. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00704.x · Cited by 85
“Candidate proteins may be related to `receptor-activity-modifying proteins' (RAMPs; McLatchie et al., 1998), transducisomes (Tsunoda et al.”
BackgroundSoluble Mediators Regulating Immunity in Early Life
Pettengill, M. A., van Haren, S. D., & Levy, O. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00457 · Cited by 89
“AM stimulates calcitonin receptor-like receptor (CALCRL) or receptor activity-modifying proteins 2 and 3 (RAMP2 and RAMP3), leading to increased cyclic-AMP (42).”
BackgroundHéroux, M., Hogue, M., Lemieux, S., & Bouvier, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701790200 · Cited by 82
Biomarker-guided personalised emergency medicine for all – hope for another hype?
Schüetz, P., Aujesky, D., Mueller, C. E., & Müller-Stich, B. P. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14079 · Cited by 92
Villa, I., Dal Fiume, C., Maestroni, A., Rubinacci, A., Ravasi, F., & Guidobono, F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00307.2002 · Cited by 82
“either with the CRLR or with the CTR (23).”
MethodBjerggaard, C., Fog, J. U., Hastrup, H., Madsen, K. L., Loland, C. J., Javitch, J. A., & Gether, U. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1863-04.2004 · Cited by 84
“There are several examples of proteins with such functions, including the so-called RAMP (receptor activity-modifying protein) proteins, which must associate with the G-protein-coupled calcitonin receptor-like receptor for this receptor to escape the ER (McLatchie et al., 1998).”
BackgroundThe structural basis of g-protein-coupled receptor function and dysfunction in human diseases
Schöneberg, T., Schulz, A. M., & Gudermann, T. W. (2007) · Springer eBooks · doi:10.1007/bfb0116587 · Cited by 95
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.